BGT vs SPL

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

41LOW

SPL

STARPHARMA FPO [SPL]

49LOW

Score Breakdown

BGT SPL
Technical
46
43
Catalyst
50
69
Sentiment
50
50
Fundamental
44
47
Momentum
42
77
Risk Gate
24
45

Key Metrics

BGT Metric SPL
$6.6MMarket Cap$304.6M
607KAvg Volume (20d)1.2M
N/AShort Interest+0.1%
$0.06152-Week High$0.790
$0.01652-Week Low$0.094
+0.0%Daily Change-0.7%
$0.017Reference Price$0.695
-202.2%ROE-14.5%
N/AProfit Margin-22.2%

Active Signals

BGT Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)

SPL Signals

MACD momentum is losing steam
Above-average volume (1.5x) on a red day — sellers in control
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (86 quarters)
Strong revenue growth (+360%)
Piotroski F-Score weak (3/9, low-confidence approx)
Substantial holder(s) ceased (1)

Ask Scout AI to compare BGT and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BGT vs TRU →BGT vs TTX →BGT vs VHL →BLS vs EMV →BLS vs IDX →
BGT Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).